A British study of 296,535 people added to evidence that the so-called obesity paradox—that being overweight or obese does not necessarily mean a greater chance of getting a heart attack—simply does not exist. Many of us could stand to lose a few pounds to lower our cardiovascular risk.
At last count, the pharmaceutical industry’s new product pipeline included more than 7,000 products in late-stage development, roughly half of which are deemed “specialty.” The reality is, our health care system is poorly equipped to address this issue head-on.
Roughly one in 20 women of childbearing age suffer from major depression. Women without private health insurance had a 2.5-fold increased risk of major depression. The antidepressants most commonly used by women with major depression were selective serotonin reuptake inhibitors (21.3%), phenylpiperazines (8.4%), and serotonin-norepinephrine reuptake inhibitors (7.2%).